|
|
|
|
LEADER |
01227cam a2200361 4500 |
001 |
PPN010259120 |
003 |
http://www.sudoc.fr/010259120 |
005 |
20200507055200.0 |
010 |
|
|
|a 0-11-320608-9
|
035 |
|
|
|a (OCoLC)489809215
|
035 |
|
|
|a sib1167440
|
100 |
|
|
|a 19980210d1975 k z0frey0103 ba
|
101 |
0 |
|
|a eng
|
102 |
|
|
|a GB
|
105 |
|
|
|a a f 001yy
|
106 |
|
|
|a r
|
181 |
|
|
|6 z01
|c txt
|2 rdacontent
|
181 |
|
1 |
|6 z01
|a i#
|b xxxe##
|
182 |
|
|
|6 z01
|c n
|2 rdamedia
|
182 |
|
1 |
|6 z01
|a n
|
183 |
|
1 |
|6 z01
|a nga
|2 rdacarrier
|
200 |
1 |
|
|a British pharmacopoeia 1973, addendum 1975
|e published on the recommendation of the Medicines Commission, pursuant to the Medicines act 1968
|
210 |
|
|
|a London
|c H. M. Stationery Off
|d 1975
|
215 |
|
|
|a 1 vol. (XIX-42, 20 p.)
|c ill.
|
300 |
|
|
|a Effective date: 1 December 1975
|
300 |
|
|
|a Prepared by the British Pharmacopoeia Commission which took office in June 1973
|
606 |
|
|
|3 PPN030943736
|a Pharmacopée
|3 PPN027228231
|y Grande-Bretagne
|2 rameau
|
712 |
0 |
2 |
|3 PPN070138168
|a General Medical Council
|c GB
|4 340
|
801 |
|
3 |
|a FR
|b SF
|g AFNOR
|
801 |
|
3 |
|a FR
|b Abes
|c 20200506
|g AFNOR
|
979 |
|
|
|a SAN
|
930 |
|
|
|5 441092101:30160617X
|b 441092101
|a 7057/2
|j u
|
998 |
|
|
|a 303280
|